Opioid Crisis: By The Numbers
U.S. — Drug overdose is the leading cause of accidental death in the United States.1
In the U.S. there were more than 63,600 drug overdose deaths in 2016and Opioids killed 42,000+ Americans; about 115 people per day; 5 times more than in 1999.2
Northeast—Between 2015 and 2016, the incidence of death from drug overdose increased significantly in the Northeast, Midwest and South Census Regions.2
New York State — InNew York from 2010 to 2015 the opioid overdose death rate doubled and the heroin death rate increased by over five times.3
In 2016, the death rate in New York was 15.1 per 100,000 persons (national rate was 13.3).4
In one year, from 2015 to 2016, drug deaths in New York State increased 29 percent — from 3,009 total deaths to 3,894.5
In 2015, New York was in the top 10 states with the highest total health care costs from opioid abuse — with $1,256 million in costs.6
New York City — In NYC, every seven hours, someone dies of a drug overdose.
More New Yorkers die of drug overdoses than homicides, suicides, and motor vehicle crashes combined.
Overdose deaths in New York City (NYC) have increased for seven consecutive years.
Fentanyl, a highly potent opioid, continues to be involved in approximately half of all overdose deaths.
Opioids are involved in more than 80% of all overdose deaths.7
Stemming the Crisis Through Medication Assisted Treatment
The consensus best-practice approach for opioid addiction treatment is Medication Assisted Treatment (MAT), which combines drug therapy (methadone, buprenorphine, or extended-release, injectable naltrexone) counseling and behavioral therapies.8
MAT = Medication + Psychological Services + Medical Services + Social Services8
In MAT, medication helps to mediate physiological impacts of addictive substances; counseling and behavioral therapies address psychosocial factors related to addiction, as well as practical challenges many people struggling with addiction have to face along the path to whole life recovery.8
MAT has been shown to deliver a 75% reduction in risk of addiction-related death among individuals who received MAT vs. those who did not.1
MAT is also associated with increasedtreatment retention, patient survival and employment rates; improved birth outcomes; and decreasedopioid use, criminal activity, and risk of HIV and Hep C.8
According to NIH leaders, “the safety and efficacy of MAT has been unequivocally established. …[M]ethadone maintenance coupled with relevant social, medical and psychological services has the highest probability of being the most effective of all treatments for opioid addiction.”1